Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Windtree Therapeutics (WINT).
Windtree Therapeutics, Inc. has entered into a Securities Purchase Agreement for a private placement of Series C Convertible Preferred Stock and Warrants, aiming to raise approximately $12.9 million. A portion of the funds was obtained by converting existing debt and preferred stock. The company anticipates using the proceeds for general corporate purposes and working capital. The deal includes specific conditions such as seeking shareholder approval for common stock issuance upon conversion or exercise of the warrants, and restrictions on equity or equity-linked securities issuance during a set period following the deal.
Learn more about WINT stock on TipRanks’ Stock Analysis page.